The report lists Marksans Pharma as a stock on radar at CMP 343, noting momentum above 354 and support at 332.
Read this note →Marksans Pharma Limited
NSE MARKSANS BSE 524404 INE750C01026
0 filings · 0 analysed
308.75
+52.30%
over 6 months
-
The report lists Marksans Pharma as a stock on radar at CMP 343, noting momentum above 354 and support at 332.
-
The note states a Buy with a buying range of 343-348, add on dip at 333, stop loss 326 and target 370 over up to 10 days, citing a bullish reversal from the 50 DEMA, higher volumes, a bullish hourly RSI setup and a higher top-higher bottom formation.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities Ltd | 23 Sep 2026, 14:50 | long | 347.60 | 370.00 | 303.70 | -100% | open by 2027-09-23 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The note states a Buy with a buying range of 343-348, add on dip at 333, stop loss 326 and target 370 over up to 10 days, citing a bullish reversal from the 50 DEMA, higher volumes, a bullish hourly RSI setup and a higher top-higher bottom formation.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief